RecruitingNot ApplicableNCT04433065

TTVR Early Feasibility Study

The Early Feasibility Study of the Transcatheter Tricuspid Valve Replacement System Transfemoral System

Sponsor

Medtronic Cardiovascular

Enrollment

150 participants

Start Date

Oct 20, 2020

Study Type

INTERVENTIONAL

Conditions

Tricuspid Regurgitation

Summary

The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding bioprosthetic valve within the tricuspid valve.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Intrepid™ TTVR System for people with tricuspid regurgitation. The study is currently recruiting participants at 20 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIntrepid™ TTVR System

Device: Intrepid™ TTVR System

Locations(20)

University of Alabama at Birmingham (UAB) Hospital

Birmingham, Alabama, United States

Abrazo Arizona Heart Hospital

Phoenix, Arizona, United States

Cedars Sinai Medical Center

Los Angeles, California, United States

California Pacific Medical Center

San Francisco, California, United States

Hartford Hospital

Hartford, Connecticut, United States

Emory University Hospital Midtown

Atlanta, Georgia, United States

University of Michigan Health System - University Hospital

Ann Arbor, Michigan, United States

Corewell Health

Grand Rapids, Michigan, United States

Abbott Northwestern Hospital

Minneapolis, Minnesota, United States

Providence Saint Patrick Hospital

Missoula, Montana, United States

The Mount Sinai Hospital

New York, New York, United States

New York-Presbyterian Hospital Columbia University Medical Center

New York, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

The Christ Hospital

Cincinnati, Ohio, United States

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

OhioHealth Riverside Methodist Hospital

Columbus, Ohio, United States

Oregon Health & Science University Hospital

Portland, Oregon, United States

UPMC Pinnacle Harrisburg Campus

Harrisburg, Pennsylvania, United States

Houston Methodist Hospital

Houston, Texas, United States

Aurora Saint Lukes Medical Center

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04433065

Related Trials

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

NCT0618368410 locations

Laplace Early Feasibility Study - Canada

NCT071710603 locations

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

NCT0409714579 locations

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

NCT055564602 locations

EFS of the DUO System for Tricuspid Regurgitation

NCT0591390815 locations